Overview

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The goal of this pilot study is to effectively treat hypertension in subjects with either known or newly diagnosed hypertension and concurrent evidence of diastolic dysfunction. Due to the unique properties of nebivolol, it is hypothesized that there will be improvements in left ventricular (LV) systolic and diastolic function manifesting as increase exercise capacity in this patient population with primarily LV diastolic dysfunction. The present study was performed to determine the effects of nebivolol on blood pressure, exercise tolerance and parameters of left ventricular systolic and diastolic function in a group of hypertensive patients with echocardiographic evidence diastolic dysfunction.
Phase:
N/A
Details
Lead Sponsor:
Mercy Research
St. John's Health System, Missouri
Collaborator:
Forest Laboratories
Treatments:
Nebivolol